Literature DB >> 21453975

Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy.

Sudhir Kumar1, Raza Ali Naqvi, Neena Khanna, D N Rao.   

Abstract

Leprosy, a chronic human disease, results from infection of Mycobacterium leprae. Defective CMI and T cell hyporesponsiveness are the major hallmark of M. leprae pathogenesis. The present study demonstrates immunological-deregulations that eventually lead to T cell anergy/hyporesponsiveness in M. lepare infection. We firstly, evaluated the membrane fluidity and antigen-presenting-lipid-raft (HLA-DR) on macrophages of leprosy patients using fluorescence anisotropy and confocal microscopy, respectively. Increased membrane fluidity and raft-out localizations of over-expressed HLA-DR towards BL/LL pole are pinpointed as major defects, may be leading to defective antigen presentation in leprosy. Furthermore, altered expression and localization of Lck, ZAP-70, etc. and their deregulated cross talks with negative regulators (CD45, Cbl-b and SHP2) turned out to be the major putative reason(s) leading to T cell hyporesponsiveness in leprosy. Deregulations of Lck-ZAP-70 cross-talk in T cells were found to be associated with cholesterol-dependent-dismantling of HLA-DR rafts in macrophages in leprosy progression. Increased molecular interactions between Cbl-b and Lck/ZAP-70 and their subsequent degradation via ubiquitinization pathway, as result of high expression of Cbl-b, were turned out to be one of the principal underlying reason leading to T cell anergy in leprosy patients. Interestingly, overexpression of SHP2 due to gradual losses of miR181a and subsequent dephosphorylation of imperative T cell signaling molecules were emerged out as another important reason associated with prevailing T cell hyporesponsiveness during leprosy progression. Thus, this study for the first time pinpointed overexpression of Cbl-b and expressional losses of miR-181 as important hallmarks of progression of leprosy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453975     DOI: 10.1016/j.molimm.2011.02.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  16 in total

1.  Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.

Authors:  Mehervani Chaduvula; A Murtaza; Namita Misra; N P Shankar Narayan; V Ramesh; H K Prasad; Rajni Rani; R K Chinnadurai; Indira Nath
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  FoxP3: A Key Player in T Regulatory Biology.

Authors:  D N Rao; Raza Ali Naqvi
Journal:  Indian J Clin Biochem       Date:  2011-02-04

Review 3.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

Review 5.  Interaction of pathogens with host cholesterol metabolism.

Authors:  Dmitri Sviridov; Michael Bukrinsky
Journal:  Curr Opin Lipidol       Date:  2014-10       Impact factor: 4.776

Review 6.  Current understanding on micro RNAs and its regulation in response to Mycobacterial infections.

Authors:  Pravin Kumar Singh; Ajay Vir Singh; Devendra Singh Chauhan
Journal:  J Biomed Sci       Date:  2013-02-28       Impact factor: 8.410

7.  T-cell regulation in lepromatous leprosy.

Authors:  Kidist Bobosha; Louis Wilson; Krista E van Meijgaarden; Yonas Bekele; Martha Zewdie; Jolien J van der Ploeg-van Schip; Markos Abebe; Jemal Hussein; Saraswoti Khadge; Kapil D Neupane; Deanna A Hagge; Ekaterina S Jordanova; Abraham Aseffa; Tom H M Ottenhoff; Annemieke Geluk
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10

Review 8.  microRNAs in mycobacterial disease: friend or foe?

Authors:  Manali D Mehta; Philip T Liu
Journal:  Front Genet       Date:  2014-07-15       Impact factor: 4.599

9.  The challenge of producing skin test antigens with minimal resources suitable for human application against a neglected tropical disease; leprosy.

Authors:  Becky L Rivoire; Stephen TerLouw; Nathan A Groathouse; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

10.  Adequate Th2-type response associates with restricted bacterial growth in latent mycobacterial infection of zebrafish.

Authors:  Milka Marjut Hammarén; Kaisa Ester Oksanen; Hanna Maria Nisula; Bruno Vincent Luukinen; Marko Pesu; Mika Rämet; Mataleena Parikka
Journal:  PLoS Pathog       Date:  2014-06-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.